Engineering low-cost protection strategies: Delphi Genetics, Belgium

Delphi Genetics, Belgium, is a small university spin-off that navigates a global market with a little help from its strategic partners. Since its lab molecular biology kits can be copied, managing IP and licensing rights are crucial.

It’s hard to imagine how a tiny company with just six employees and half a million euros in sales survives in a massive global market. The answer for Delphi Genetics, a Walloon, Belgium-based maker of kits for DNA engineering used by pharmaceutical and university research labs, has been to rely on support from its parent university; to keep close ties to its global distributors and licensees; and to maintain a strong patent position that supports its core technological invention.

Source: EPO